Wilcoxia MR 4 Tablet is a combination medication containing Etoricoxib 60 mg and Thiocolchicoside 4 mg, formulated to provide effective relief from musculoskeletal pain and inflammation. Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that reduces the synthesis of prostaglandins, thereby alleviating pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. Thiocolchicoside is a muscle relaxant with anti-inflammatory and analgesic properties, acting as a selective antagonist of GABA and glycine receptors, which helps reduce muscle spasms and stiffness. The combination of these two active ingredients offers a synergistic effect, targeting both inflammatory pain and muscle spasm, making Wilcoxia MR 4 suitable for managing acute musculoskeletal disorders, low back pain, and post-traumatic muscle injuries. It is recommended to be used under medical supervision, with caution in patients with a history of cardiovascular disease, gastrointestinal disorders, or hypersensitivity to NSAIDs or muscle relaxants. Common side effects may include gastrointestinal discomfort, dizziness, and headache. Wilcoxia MR 4 Tablet should be taken as prescribed, with regular monitoring to ensure safety and efficacy during the course of treatment.